<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml producer="poppler" version="23.12.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="600">
	<fontspec id="0" size="10" family="Minion" color="#231f20"/>
	<fontspec id="1" size="10" family="Minion" color="#000000"/>
	<fontspec id="2" size="10" family="MinionExp" color="#231f20"/>
	<fontspec id="3" size="12" family="Minion-Black" color="#231f20"/>
	<fontspec id="4" size="10" family="Minion" color="#231f20"/>
	<fontspec id="5" size="10" family="MinionProMath" color="#231f20"/>
<text top="45" left="51" width="5" height="9" font="0">2</text>
<text top="45" left="433" width="116" height="9" font="0">Pain Research and Treatment</text>
<text top="74" left="51" width="240" height="9" font="0">chronic fatigue, and irritable bowel all score significantly</text>
<text top="85" left="51" width="240" height="9" font="0">higher on the neuroticism scale compared to healthy con-</text>
<text top="97" left="51" width="240" height="9" font="0">trols. These findings may be biased by health seeking behavi-</text>
<text top="108" left="51" width="199" height="9" font="0">our as it itself has also been linked to neuroticism <a href="">[</a></text>
<text top="108" left="250" width="10" height="9" font="1"><a href="">12</a></text>
<text top="108" left="260" width="31" height="9" font="0"><a href="">]. </a>There</text>
<text top="119" left="51" width="240" height="9" font="0">also have been a number of other studies that suggest a causal</text>
<text top="131" left="51" width="4" height="9" font="0">e</text>
<text top="128" left="55" width="6" height="13" font="2">ﬀ</text>
<text top="131" left="61" width="230" height="9" font="0">ect between neuroticism and health. Pain mechanisms are</text>
<text top="142" left="51" width="240" height="9" font="0">heighted by neuroticism reflecting that psychosocial factors</text>
<text top="153" left="51" width="143" height="9" font="0">influence biological mechanisms <a href="">[</a></text>
<text top="153" left="193" width="10" height="9" font="1"><a href="">12</a></text>
<text top="153" left="203" width="88" height="9" font="0"><a href="">]. </a>Furthermore, both</text>
<text top="165" left="51" width="240" height="9" font="0">neuroticism and extraversion have been associated with the</text>
<text top="176" left="51" width="240" height="9" font="0">regulation of the autonomic nervous system and pain re-</text>
<text top="188" left="51" width="38" height="9" font="0">sponses <a href="">[</a></text>
<text top="188" left="89" width="10" height="9" font="1"><a href="">13</a></text>
<text top="188" left="98" width="193" height="9" font="0">]. Neuroticism will also influence recall and in</text>
<text top="199" left="51" width="240" height="9" font="0">turn memory and is an issue pertinent to patients with FM</text>
<text top="210" left="51" width="4" height="9" font="0"><a href="">[</a></text>
<text top="210" left="54" width="10" height="9" font="1"><a href="">14</a></text>
<text top="210" left="64" width="6" height="9" font="0"><a href="">].</a></text>
<text top="222" left="66" width="109" height="9" font="0">Limited and inconsistent <a href="">[</a></text>
<text top="222" left="174" width="10" height="9" font="1"><a href="">13</a></text>
<text top="222" left="184" width="107" height="9" font="0"><a href="">] </a>studies have investigated</text>
<text top="233" left="51" width="240" height="9" font="0">the role of personality in the development, maintenance, and</text>
<text top="244" left="51" width="240" height="9" font="0">exacerbation of symptoms associated with FM. Previous</text>
<text top="256" left="51" width="240" height="9" font="0">studies focussed on personality using scales based on levels of</text>
<text top="267" left="51" width="240" height="9" font="0">psychopathology, such as the Minnesota Multiphasic Per-</text>
<text top="279" left="51" width="240" height="9" font="0">sonality Inventory [MMPI I/2], or take a psychobiological/</text>
<text top="290" left="51" width="240" height="9" font="0">biological relevance approach using scales such as the Tem-</text>
<text top="301" left="51" width="240" height="9" font="0">perament and Character Inventory (TCI) or Karolinska scale</text>
<text top="313" left="51" width="60" height="9" font="0">of personality <a href="">[</a></text>
<text top="313" left="111" width="10" height="9" font="1"><a href="">15</a></text>
<text top="313" left="120" width="171" height="9" font="0">]. It has been shown that high levels of neu-</text>
<text top="324" left="51" width="240" height="9" font="0">roticism link to increased perception of pain and other symp-</text>
<text top="335" left="51" width="108" height="9" font="0">toms associated with FM <a href="">[</a></text>
<text top="335" left="159" width="10" height="9" font="1"><a href="">16</a></text>
<text top="335" left="168" width="2" height="9" font="0">,</text>
<text top="335" left="174" width="10" height="9" font="1"><a href="">17</a></text>
<text top="335" left="183" width="108" height="9" font="0">]. This may occur through</text>
<text top="347" left="51" width="21" height="9" font="0">the e</text>
<text top="344" left="71" width="6" height="13" font="2">ﬀ</text>
<text top="347" left="77" width="214" height="9" font="0">ect of personality on the type of coping techniques</text>
<text top="358" left="51" width="175" height="9" font="0">used to deal with pain rather than a direct e</text>
<text top="356" left="225" width="6" height="13" font="2">ﬀ</text>
<text top="358" left="231" width="60" height="9" font="0">ect on the pain</text>
<text top="369" left="51" width="25" height="9" font="0">itself <a href="">[</a></text>
<text top="369" left="76" width="10" height="9" font="1"><a href="">12</a></text>
<text top="369" left="85" width="2" height="9" font="0">,</text>
<text top="369" left="90" width="10" height="9" font="1"><a href="">17</a></text>
<text top="369" left="99" width="6" height="9" font="0">].</text>
<text top="381" left="66" width="225" height="9" font="0">The key domains contributing to the clinical phenotype</text>
<text top="392" left="51" width="240" height="9" font="0">of FM, namely, pain, poor sleep, fatigue, cognitive dys-</text>
<text top="404" left="51" width="240" height="9" font="0">function (confusion), emotional distress (anxiety and</text>
<text top="415" left="51" width="240" height="9" font="0">depression), and stress are well defined within the American</text>
<text top="426" left="51" width="210" height="9" font="0">College of Rheumatology [ACR] 1990 classification <a href="">[</a></text>
<text top="426" left="260" width="10" height="9" font="1"><a href="">18</a></text>
<text top="426" left="270" width="21" height="9" font="0"><a href="">] </a>and</text>
<text top="438" left="51" width="82" height="9" font="0">the 2010 diagnostic <a href="">[</a></text>
<text top="438" left="133" width="10" height="9" font="1"><a href="">19</a></text>
<text top="438" left="142" width="149" height="9" font="0">] criteria for FM. We aimed to explore</text>
<text top="449" left="51" width="240" height="9" font="0">whether personality traits influence these characteristic</text>
<text top="460" left="51" width="240" height="9" font="0">symptoms of FM. We surveyed young women with FM in</text>
<text top="472" left="51" width="219" height="9" font="0">order to minimize long-term secondary and adaptive e</text>
<text top="469" left="270" width="6" height="13" font="2">ﬀ</text>
<text top="472" left="276" width="15" height="9" font="0">ects</text>
<text top="483" left="51" width="240" height="9" font="0">of the condition on these FM outcomes. We specifically</text>
<text top="495" left="51" width="240" height="9" font="0">wished to see if the characteristic FM symptoms of pain,</text>
<text top="506" left="51" width="240" height="9" font="0">sleep, confusion, depression, anxiety, and stress associate</text>
<text top="517" left="51" width="240" height="9" font="0">with personality traits and if so how these factors might</text>
<text top="529" left="51" width="37" height="9" font="0">interlink.</text>
<text top="552" left="51" width="56" height="11" font="3"><b>2. Methods</b></text>
<text top="574" left="51" width="240" height="9" font="4"><i>2.1. Ethics. </i>Ethics approval was obtained through relevant</text>
<text top="585" left="51" width="240" height="9" font="0">committees of Monash University and Monash Medical Cen-</text>
<text top="596" left="51" width="103" height="9" font="0">tre, Melbourne, Australia.</text>
<text top="621" left="51" width="240" height="9" font="4"><i>2.2. Subjects. </i>The participants in this study consisted of vol-</text>
<text top="633" left="51" width="240" height="9" font="0">unteer women who were sourced from a variety of areas in-</text>
<text top="644" left="51" width="240" height="9" font="0">cluding a FM self-management program, notices in local</text>
<text top="656" left="51" width="240" height="9" font="0">news-papers, a fibromyalgia treatment clinic, and local rheu-</text>
<text top="667" left="51" width="240" height="9" font="0">matologists. Twenty-five female FM patients fulfilling ACR</text>
<text top="678" left="51" width="240" height="9" font="0">1990 classification criteria and 27 female HCs, all healthy</text>
<text top="690" left="51" width="240" height="9" font="0">individuals with no pain condition and recruited by word of</text>
<text top="701" left="51" width="238" height="9" font="0">mouth were identified. All were under age of 39 years of age.</text>
<text top="722" left="51" width="240" height="9" font="4"><i>2.3. Procedures. </i>All participants were sent written informa-</text>
<text top="733" left="51" width="240" height="9" font="0">tion regarding the study along with a consent form which,</text>
<text top="74" left="309" width="240" height="9" font="0">when signed, was followed by a series of questionnaires.</text>
<text top="85" left="309" width="225" height="9" font="0">These included the Fibromyalgia Impact Questionnaire <a href="">[</a></text>
<text top="85" left="533" width="10" height="9" font="1"><a href="">20</a></text>
<text top="85" left="543" width="6" height="9" font="0"><a href="">],</a></text>
<text top="97" left="309" width="107" height="9" font="0">the Profile of Mood States <a href="">[</a></text>
<text top="97" left="416" width="10" height="9" font="1"><a href="">21</a></text>
<text top="97" left="425" width="123" height="9" font="0">], and the Perceived Stress Scale</text>
<text top="108" left="309" width="4" height="9" font="0"><a href="">[</a></text>
<text top="108" left="312" width="10" height="9" font="1"><a href="">22</a></text>
<text top="108" left="322" width="227" height="9" font="0"><a href="">]. </a>Participating FM women were also contacted 12</text>
<text top="119" left="309" width="240" height="9" font="0">months later to complete the same battery of questionnaires,</text>
<text top="131" left="309" width="112" height="9" font="0">with a response rate of 56%.</text>
<text top="156" left="309" width="240" height="9" font="4"><i>2.4. Instruments. </i>The following instruments were applied to</text>
<text top="167" left="309" width="240" height="9" font="0">all FM and HC subjects at time zero and to 56% of FM pa-</text>
<text top="179" left="309" width="89" height="9" font="0">tients 12 months later.</text>
<text top="197" left="323" width="180" height="9" font="0">(1) The Big 5 Personality Inventory (BFI) <a href="">[</a></text>
<text top="197" left="503" width="10" height="9" font="1"><a href="">11</a></text>
<text top="197" left="513" width="36" height="9" font="0">]: a vali-</text>
<text top="208" left="339" width="210" height="9" font="0">dated 44-item personality scale, scored as 1 (disagree</text>
<text top="220" left="339" width="210" height="9" font="0">strongly) through 5 (agree strongly) to indicate the</text>
<text top="231" left="339" width="210" height="9" font="0">extent of agreement with the items. The 44 items</text>
<text top="242" left="339" width="210" height="9" font="0">comprise 5 subscales of extraversion, agreeableness,</text>
<text top="254" left="339" width="185" height="9" font="0">conscientiousness, neuroticism, and openness.</text>
<text top="269" left="323" width="200" height="9" font="0">(2) Fibromyalgia Impact Questionnaire (FIQ) <a href="">[</a></text>
<text top="269" left="524" width="10" height="9" font="1"><a href="">20</a></text>
<text top="269" left="533" width="16" height="9" font="0">]: a</text>
<text top="280" left="339" width="210" height="9" font="0">validated 20-item functional ability questionnaire,</text>
<text top="292" left="339" width="210" height="9" font="0">which measures how an individual’s symptom char-</text>
<text top="303" left="339" width="210" height="9" font="0">acteristics impact their daily functioning for the pre-</text>
<text top="314" left="339" width="210" height="9" font="0">ceding week. Individual subscales include sleep,</text>
<text top="326" left="339" width="210" height="9" font="0">depression, anxiety, and pain and use a 0 to 10 cm</text>
<text top="337" left="339" width="210" height="9" font="0">visual analogue scale (VAS), measuring left of line for</text>
<text top="348" left="339" width="210" height="9" font="0">“no impact of subscale” through to the far right,</text>
<text top="360" left="339" width="96" height="9" font="0">“worst possible impact”.</text>
<text top="375" left="323" width="138" height="9" font="0">(3) Perceived Stress Scale (PSS) <a href="">[</a></text>
<text top="375" left="461" width="10" height="9" font="1"><a href="">22</a></text>
<text top="375" left="471" width="78" height="9" font="0">]: a validated scale</text>
<text top="386" left="339" width="210" height="9" font="0">that assesses the degree an individual experiences</text>
<text top="398" left="339" width="210" height="9" font="0">feelings of being overwhelmed by stressful life events</text>
<text top="409" left="339" width="210" height="9" font="0">over the past month. The scale is a 10-item, 5-point</text>
<text top="420" left="339" width="210" height="9" font="0">likert scale ranging from 0 (never) to 4 (very often)</text>
<text top="432" left="339" width="131" height="9" font="0">with scores ranging from 0 to 40.</text>
<text top="447" left="323" width="149" height="9" font="0">(4) Profile of Mood States (POMS) <a href="">[</a></text>
<text top="447" left="472" width="10" height="9" font="1"><a href="">21</a></text>
<text top="447" left="482" width="67" height="9" font="0"><a href="">] </a>confusion sub-</text>
<text top="458" left="339" width="210" height="9" font="0">scale: a validated scale that measures individual</text>
<text top="469" left="339" width="210" height="9" font="0">aspects of mood as well as a total overall mood</text>
<text top="481" left="339" width="210" height="9" font="0">score. The POMS identifies adjective words that de-</text>
<text top="492" left="339" width="210" height="9" font="0">scribe feelings that are indicative of mood states. The</text>
<text top="504" left="339" width="210" height="9" font="0">questionnaire asks individuals to rate on a scale</text>
<text top="515" left="339" width="210" height="9" font="0">from zero (not at all) to four (extremely) which</text>
<text top="526" left="339" width="210" height="9" font="0">best describes how they have felt over the past</text>
<text top="538" left="339" width="210" height="9" font="0">week. The scale includes a total of 65 definitions that</text>
<text top="549" left="339" width="210" height="9" font="0">represent the 6 subscales that include Tension-Anx-</text>
<text top="560" left="339" width="210" height="9" font="0">iety, Depression-Dejection, Anger-Hostility, Vigour,</text>
<text top="572" left="339" width="210" height="9" font="0">Fatigue, and Confusion. A total mood score is</text>
<text top="583" left="339" width="210" height="9" font="0">obtained by summing all subscale scores with vigour</text>
<text top="595" left="339" width="210" height="9" font="0">inversed. The subscale of confusion was used to</text>
<text top="606" left="339" width="210" height="9" font="0">represent the cognitive dysfunction seen in FM. The</text>
<text top="617" left="339" width="210" height="9" font="0">single word items that reflect confusion include be-</text>
<text top="629" left="339" width="210" height="9" font="0">wil-dered, confused, unable to concentrate, forgetful,</text>
<text top="640" left="339" width="65" height="9" font="0">uncertain, and e</text>
<text top="638" left="403" width="8" height="13" font="2">ﬃ</text>
<text top="640" left="411" width="87" height="9" font="0">cient (score reversed).</text>
<text top="665" left="309" width="240" height="9" font="4"><i>2.5. Statistical Analysis. </i>Initial descriptive analysis was con-</text>
<text top="677" left="309" width="240" height="9" font="0">ducted, along with normality checks, using SPSS (PASW</text>
<text top="688" left="309" width="195" height="9" font="0">version). Chi-squared test was used to test for di</text>
<text top="686" left="503" width="6" height="13" font="2">ﬀ</text>
<text top="688" left="509" width="40" height="9" font="0">erences in</text>
<text top="699" left="309" width="85" height="9" font="0">group demographics.</text>
<text top="697" left="395" width="3" height="13" font="5"><i>t</i></text>
<text top="699" left="399" width="150" height="9" font="0">-Tests, means and standard deviations</text>
<text top="711" left="309" width="121" height="9" font="0">were used to explore the di</text>
<text top="708" left="430" width="6" height="13" font="2">ﬀ</text>
<text top="711" left="436" width="113" height="9" font="0">erences between groups in</text>
<text top="722" left="309" width="240" height="9" font="0">symptom characteristics and stability of personality traits.</text>
<text top="733" left="309" width="188" height="9" font="0">ANOVAs were performed to compare the di</text>
<text top="731" left="497" width="6" height="13" font="2">ﬀ</text>
<text top="733" left="502" width="47" height="9" font="0">erences be-</text>
</page>
</pdf2xml>
